SK Chemicals Jumps 15% After Swinging to Q2 Profit
A view of SK Chemicals’ headquarters in Pangyo. SK Chemicals SK Chemicals (285130.KS) shares surged nearly 15% in…
SK Bioscience Q2 Loss Narrows 58% as German Unit IDT Turnaround Gains Traction — BigGo Finance
SK Bioscience has laid the groundwork for a return to profitability, slashing its second-quarter operating loss by nearly…
SK Bioscience, EcoPro Materials Hit Record Lows in Market Selloff
The Kospi and Kosdaq indexes are displayed on an electronic board in the dealing room at the headquarters…
SK Bioscience stock trades steady as vaccine pipeline and earnings metrics shape outlook
SK Bioscience stock sits at the intersection of Korea’s biopharmaceutical innovation and global vaccine demand, with the company…
SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework. SK bioscience,…
IDT Eyes Capacity Expansion, M&A to Build on SK Synergies
Federico Polano, Chief Commercial Officer of IDT Biologika, speaks during an interview with Seoul Economic Daily at BIO…
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly…
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
First UNICEF procurement contract strengthens SK bioscience’s presence in global public procurement markets Dual-hemisphere supply programs enhance manufacturing…
SK Bioscience Hosts First Family Day at New Songdo Headquarters
SK Bioscience CEO Ahn Jae-yong (center) greets employees’ families at the event. Photo courtesy of SK Bioscience SK…
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
SK bioscience’s board approval follows the Financial Services Commission’s May 28 announcement selecting the company as a beneficiary…
SK Bioscience Secures 300 Billion Won from National Growth Fund for Pneumococcal Vaccine
SK Bioscience’s headquarters in Songdo. Photo courtesy of SK Bioscience SK Bioscience (302440.KS) is accelerating development of a…
SK bioscience collaborates with Colombia’s government-led $260 M vaccine localisation initiative
SK bioscience collaborates with Colombia’s government-led $260 M vaccine localisation initiative May 27, 2026 | Wednesday | News…